Collagen biomarkers and subclinical interstitial lung disease: The Multi-Ethnic Study of Atherosclerosis
Respiratory Medicine Jun 09, 2018
Madahar P, et al. - Given lung fibrosis is attributed to derangements in extracellular matrix remodeling, a process driven by collagen turnover, researchers performed this cross-sectional analysis to study the association of two collagen biomarkers carboxy-terminal telopeptide of collagen type I (ICTP) and amino-terminal propeptide of type III procollagen (PIIINP), with subclinical interstitial lung disease (ILD) in adults (age 45–84 years) in the Multi-Ethnic Study of Atherosclerosis. They found that higher levels of collagen biomarkers were related to greater high attenuation areas independent of gender, race and smoking status. This finding implied that before the onset of clinically evident disease, extracellular matrix remodeling may accompany subclinical ILD.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries